Want to join the conversation?
$STJ received an approval from FDA for its BurstDR therapy for chronic pain. The company expects additional product approvals during 4Q16 to drive further sales growth in 2017. In Europe, $STJ expects to receive approval for its next-generation Confirm implantable cardiac monitor technology before the end of 2016.
Visa ($V) set to release it earning after market close today. With new CEO resigning so close to the earnings, should we expect to see any surprises? Visa has been making strong moves with Visa Europe acquisition, partnership with PayPal and a 15% increase if quarterly dividends.
Kimberly Clark Corp ($KMB) has been in decline for most of the year, the stock has also not been getting any analyst love. Will today’s earnings break the trend? Revenue has been up and down in the last four quarters, let us see what this quarter brings.
$KMB down close to 4% after it misses on earnings and revenue. Forecasts are lower for the year.